Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-expressed sequence 29 protein (TEX29) is a protein encoded by the TEX29 gene located on human chromosome 13. It is classified as a protein-coding gene and is predicted to be membrane-associated. TEX29 is part of a protein family found in eukaryotes, typically ranging from 39 to 150 amino acids in length. Although allied with some rare diseases (such as Crouzon Syndrome with acanthosis nigricans and spastic paraplegia 2, X-linked), there is currently no experimental evidence supporting well-defined molecular functions, biological processes, or involvement as a recognized drug target or biomarker. Its biological and biomedical importance remains unclear, and it is not presently classified within any mainstream therapeutic target class or disease mechanism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-expressed sequence 29 protein (TEX29).